Cowen and Company’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-22,865
| Closed | -$2.2M | – | 614 |
|
|
2023
Q4 | $2.2M | Buy |
+22,865
| New | +$2.2M | 0.14% | 107 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 587 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 557 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 607 |
|
|
2022
Q2 | – | Sell |
-9,312
| Closed | -$718K | – | 565 |
|
|
2022
Q1 | $718K | Buy |
9,312
+3,196
| +52% | +$246K | 0.07% | 119 |
|
|
2021
Q4 | $540K | Buy |
+6,116
| New | +$540K | 0.05% | 196 |
|
|
2021
Q3 | – | Sell |
-5,145
| Closed | -$429K | – | 415 |
|
|
2021
Q2 | $429K | Sell |
5,145
-5,036
| -49% | -$420K | 0.02% | 180 |
|
|
2021
Q1 | $769K | Buy |
+10,181
| New | +$769K | 0.05% | 143 |
|
|
2020
Q4 | – | Sell |
-83
| Closed | -$6K | – | 256 |
|
|
2020
Q3 | $6K | Buy |
+83
| New | +$6K | ﹤0.01% | 263 |
|